Pancreatic islets implanted in an irreversible electroporation generated extracellular matrix in the liver

1 Ballinger WF, Lacy PE. Transplantation of intact pancreatic islets in rats. Surgery 1972; 72: 175-86. PMID: 4262169 Ballinger WF Lacy PE Transplantation of intact pancreatic islets in rats. Surgery 1972 72 17586 PMID: 4262169Search in Google Scholar

2 Kemp CB, Knight MJ, Scharp DW, Ballinger WF, Lacy PE. Effect of transplantation site on the results of pancreatic islet isografts in diabetic rats. Diabetologia 1973; 9: 486-91. doi: 10.1007/BF00461694 Kemp CB Knight MJ Scharp DW Ballinger WF Lacy PE Effect of transplantation site on the results of pancreatic islet isografts in diabetic rats. Diabetologia 1973 9 48691 doi: 10.1007/BF00461694Open DOISearch in Google Scholar

3 Shapiro AJ, Ricordi C, Hering BJ, Auchincloss H, Lindblad R, Robertson RP, et al. International trial of the Edmonton protocol for islet transplantation. N Engl J Med 2006; 355: 1318-30. doi: 10.1056/NEJMoa061267 Shapiro AJ Ricordi C Hering BJ Auchincloss H Lindblad R Robertson RP et al. International trial of the Edmonton protocol for islet transplantation. N Engl J Med 2006 355 131830 doi: 10.1056/NEJMoa061267Open DOISearch in Google Scholar

4 McCall M, Shapiro AJ. Update on islet transplantation. Cold Spring Harb Perspect Med 2012; 2: a007823. doi: 10.1101/cshperspect.a007823 McCall M Shapiro AJ Update on islet transplantation Cold Spring Harb Perspect Med 2012 2 a007823 doi: 10.1101/cshperspect.a007823Open DOISearch in Google Scholar

5 Korsgren O, Nilsson B, Berne C, Felldin M, Foss A, Kallen R, et al. Current status of clinical islet transplantation. Transplantation 2005; 79: 1289-93. doi: 10.1097/01.tp.0000157273.60147.7c Korsgren O Nilsson B Berne C Felldin M Foss A Kallen R et al. Current status of clinical islet transplantation. Transplantation 2005 79 128993 doi: 10.1097/01.tp.0000157273.60147.7cOpen DOISearch in Google Scholar

6 Biarnés M, Montolio M, Nacher V, Raurell M, Soler J, Montanya E. β-cell death and mass in syngeneically transplanted islets exposed to short-and long-term hyperglycemia. Diabetes 2002; 51: 66-72. doi: 10.2337/diabetes.51.1.66 Biarnés M MontolioM NacherV RaurellM SolerJ MontanyaE β-cell death and mass in syngeneically transplanted islets exposed to short-and long-term hyperglycemia Diabetes 2002 51 6672 doi: 10.2337/diabetes.51.1.66Open DOISearch in Google Scholar

7 Bennet W, Groth CG, Larsson R, Nilsson B, Korsgren O. Isolated human islets trigger an instant blood mediated inflammatory reaction: implications for in-traportal islet transplantation as a treatment for patients with type 1 diabetes. Upsala J Med Sci 2000; 105: 125-33. doi: 10.1517/03009734000000059 Bennet W Groth CG Larsson R Nilsson B Korsgren O Isolated human islets trigger an instant blood mediated inflammatory reaction: implications for in-traportal islet transplantation as a treatment for patients with type 1 diabetes. Upsala J Med Sci 2000 105 12533 doi: 10.1517/03009734000000059Open DOISearch in Google Scholar

8 Silva IB, Kimura CH, Colantoni VP, Sogayar MC. Stem cells differentiation into insulin-producing cells (IPCs): recent advances and current challenges. Stem Cell Res Ther 2022; 13: 1-24. doi: 10.1186/s13287-022-02977-y Silva IB Kimura CH Colantoni VP Sogayar MC Stem cells differentiation into insulin-producing cells (IPCs): recent advances and current challenges. Stem Cell Res Ther 2022 13 124 doi: 10.1186/s13287-022-02977-yOpen DOISearch in Google Scholar

9 Cayabyab F, Nih LR, Yoshihara E. Advances in pancreatic islet transplantation sites for the treatment of diabetes. Front Endocrinol 2021: 12: 732431. doi: 10.3389/fendo.2021.732431 Cayabyab F Nih LR Yoshihara E Advances in pancreatic islet transplantation sites for the treatment of diabetes. Front Endocrinol 2021 12 732431 doi: 10.3389/fendo.2021.732431Open DOISearch in Google Scholar

10 Rickels MR, Robertson RP. Pancreatic islet transplantation in humans: recent progress and future directions. Endocr Rev 2019; 40: 631-68. doi: 10.1210/ er.2018-00154 Rickels MR Robertson RP Pancreatic islet transplantation in humans: recent progress and future directions. Endocr Rev 2019 40 63168 doi: 10.1210/er.2018-00154Open DOISearch in Google Scholar

11 Fujita I, Utoh R, Yamamoto M, Okano T, Yamato M. The liver surface as a favorable site for islet cell sheet transplantation in type 1 diabetes model mice. Regen Ther 2018; 8: 65-72. doi: 10.1016/j.reth.2018.04.002 Fujita I Utoh R Yamamoto M Okano T Yamato M The liver surface as a favorable site for islet cell sheet transplantation in type 1 diabetes model mice. Regen Ther 2018 8 6572 doi: 10.1016/j.reth.2018.04.002Open DOISearch in Google Scholar

12 Koethe Y, Wilson N, Narayanan G. Irreversible electroporation for colorectal cancer liver metastasis: a review. Int J Hyperthermia 2022; 39: 682-7. doi: 10.1080/02656736.2021.2008025 Koethe Y Wilson N Narayanan G Irreversible electroporation for colorectal cancer liver metastasis: a review. Int J Hyperthermia 2022 39 6827 doi: 10.1080/02656736.2021.2008025Open DOISearch in Google Scholar

13 Davalos RV, Mir LM, Rubinsky B. Tissue ablation with irreversible electroporation. Ann Biomed Eng. 2005; 33: 223-31. doi: 10.1007/s10439-005-8981-8 Davalos RV Mir LM Rubinsky B Tissue ablation with irreversible electroporation Ann Biomed Eng. 2005 33 22331 doi: 10.1007/s10439-005-8981-8Open DOISearch in Google Scholar

14 Rubinsky B, Onik G, Mikus P. Irreversible electroporation: a new ablation modality—clinical implications. Technol Cancer Res Treat 2007; 6: 37-48. doi: 10.1177/153303460700600106 Rubinsky B Onik G Mikus P Irreversible electroporation: a new ablation modality—clinical implications. Technol Cancer Res Treat 2007 6 3748 doi: 10.1177/153303460700600106Open DOISearch in Google Scholar

15 Al-Sakere B, André F, Bernat C, Connault E, Opolon P, Davalos RV, et al. Tumor ablation with irreversible electroporation. PloS ONE 2007; 2: e1135. doi: 10.1371/journal.pone.0001135 Al-Sakere B André F Bernat C Connault E Opolon P Davalos RV et al. Tumor ablation with irreversible electroporation. PloS ONE 2007 2 e1135 doi: 10.1371/journal.pone.0001135Open DOISearch in Google Scholar

16 Zhang Y, Lyu C, Liu Y, Lv Y, Chang TT, Rubinsky B. Molecular and histological study on the effects of non-thermal irreversible electroporation on the liver. Biochem Biophys Res Commun 2018; 500: 665-70. doi: 10.1016/j. bbrc.2018.04.132 Zhang Y Lyu C Liu Y Lv Y Chang TT Rubinsky B Molecular and histological study on the effects of non-thermal irreversible electroporation on the liver. Biochem Biophys Res Commun 2018 500 66570 doi: 10.1016/j.bbrc.2018.04.132Open DOISearch in Google Scholar

17 Phillips MA, Narayan R, Padath T, Rubinsky B. Irreversible electroporation on the small intestine. Br J Cancer 2012; 106: 490-5. doi: 10.1038/bjc.2011.582 Phillips MA Narayan R Padath T Rubinsky B Irreversible electroporation on the small intestine. Br J Cancer 2012 106 4905 doi: 10.1038/bjc.2011.582Open DOISearch in Google Scholar

18 Hitpass L, Distelmaier M, Neumann UP, Schöning W, Isfort P, Keil S, et al. Recurrent colorectal liver metastases in the liver remnant after major liver surgery – IRE as a salvage local treatment when resection and thermal ablation are unsuitable. Cardiovasc Intervent Radiol 2022; 45: 182-9. doi: 10.1007/s00270-021-02981-4 Hitpass L Distelmaier M Neumann UP Schöning W Isfort P Keil S et al. Recurrent colorectal liver metastases in the liver remnant after major liver surgery – IRE as a salvage local treatment when resection and thermal ablation are unsuitable. Cardiovasc Intervent Radiol 2022 45 1829 doi: 10.1007/s00270-021-02981-4Open DOISearch in Google Scholar

19 Lee EW, Shahrouki P, Peterson S, Tafti BA, Ding PX, Kee ST. Safety of irreversible electroporation ablation of the pancreas. Pancreas 2021; 50: 1281-6. doi: 10.1097/MPA.0000000000001916 Lee EW Shahrouki P Peterson S Tafti BA Ding PX Kee ST Safety of irreversible electroporation ablation of the pancreas. Pancreas 2021 50 12816 doi: 10.1097/MPA.0000000000001916Open DOISearch in Google Scholar

20 Maor E, Ivorra A, Mitchell JJ, Rubinsky B. Vascular smooth muscle cells ablation with endovascular nonthermal irreversible electroporation. J Vasc Interv Radiol 2010; 21: 1708-15. doi: 10.1016/j.jvir.2010.06.024 Maor E Ivorra A Mitchell JJ Rubinsky B Vascular smooth muscle cells ablation with endovascular nonthermal irreversible electroporation J Vasc Interv Radiol 2010 21 170815 doi: 10.1016/j.jvir.2010.06.024Open DOISearch in Google Scholar

21 Maor E, Ivorra A, Leor J, Rubinsky B. Irreversible electroporation attenuates neointimal formation after angioplasty. IEEE Trans Biomed Eng 2008; 55: 2268-74. doi: 10.1109/TBME.2008.923909 Maor E Ivorra A Leor J Rubinsky B Irreversible electroporation attenuates neointimal formation after angioplasty IEEE Trans Biomed Eng 2008 55 226874 doi: 10.1109/TBME.2008.923909Open DOISearch in Google Scholar

22 Phillips M, Maor E, Rubinsky B. Principles of tissue engineering with non-thermal irreversible electroporation. J Heat Transfer 2011; 133: 011004. doi: 10.1115/1.4002301. Phillips M Maor E Rubinsky B Principles of tissue engineering with non-thermal irreversible electroporation. J Heat Transfer 2011 133 011004 doi: 10.1115/1.4002301.Open DOISearch in Google Scholar

23 Phillips M, Maor E, Rubinsky B. Nonthermal irreversible electroporation for tissue decellularization. J Biomech Eng 2010; 132: 091003. doi: 10.1115/1.4001882 Phillips M Maor E Rubinsky B Nonthermal irreversible electroporation for tissue decellularization. J Biomech Eng 2010 132 091003 doi: 10.1115/1.4001882Open DOISearch in Google Scholar

24 Phillips M, Maor E, Rubinsky B. Lavee J. Extracellular matrix material created using non-thermal irreversible electroporation. US Patent 08835166, Sep 16 2014. Phillips M Maor E Rubinsky B Lavee J Extracellular matrix material created using non-thermal irreversible electroporation US Patent 08835166 Sep 16 2014Search in Google Scholar

25 Chang TT, Zhou VX, Rubinsky B. Using non-thermal irreversible electroporation to create an in vivo niche for exogenous cell engraftment. Biotechniques 2017; 62: 229-31. doi: 10.2144/000114547 Chang TT Zhou VX Rubinsky B Using non-thermal irreversible electroporation to create an in vivo niche for exogenous cell engraftment. Biotechniques 2017 62 22931 doi: 10.2144/000114547Open DOISearch in Google Scholar

26 Lopez-Ichikawa M, Vu NK, Nijagal A, Rubinsky B, Chang TT. Neutrophils are important for the development of pro-reparative macrophages after irreversible electroporation of the liver in mice. Sci Rep 2021; 11: 1-3. doi: 10.1038/s41598-021-94016-8 Lopez-Ichikawa M VuNK NijagalA RubinskyB ChangTT Neutrophils are important for the development of pro-reparative macrophages after irreversible electroporation of the liver in mice Sci Rep 2021 11 13 doi: 10.1038/s41598-021-94016-8Open DOISearch in Google Scholar

27 Zhou VX, Lolas M, Chang TT. Direct orthotopic implantation of hepatic organoids. J. Surg. Res 2017; 211: 251-60. doi: 10.1016/j.jss.2016.12.028 Zhou VX Lolas M Chang TT Direct orthotopic implantation of hepatic organoids. J. Surg. Res 2017 211 25160 doi: 10.1016/j.jss.2016.12.028Open DOISearch in Google Scholar

28 Szot GL, Koudria P, Bluestone JA. Murine pancreatic islet isolation. J Vis Exp 2007; 22: e255. doi: 10.3791/255 Szot GL Koudria P Bluestone JA Murine pancreatic islet isolation J Vis Exp 2007 22 e255 doi: 10.3791/255Open DOISearch in Google Scholar

29 Michalopoulos GK. Liver regeneration. J. Cell. Physiol 2007; 213: 286-300. doi: 10.1002/jcp.21172 Michalopoulos GK. Liver regeneration. J. Cell. Physiol 2007 213 286300 doi: 10.1002/jcp.21172Open DOISearch in Google Scholar